All News about Gilead Sciences![]()
Kite Pharma's CAR T-Cell Therapy Wins European Approval In Refractory Leukemia Setting
September 07, 2022
Via Benzinga
![]() ![]() ![]() ![]()
Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback
September 02, 2022
Via Benzinga
![]() ![]() ![]()
Gilead Sciences to Present at Upcoming Investor Conferences
August 29, 2022
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Gilead to Acquire Remaining Worldwide Rights of Trodelvy®
August 15, 2022
Via Business Wire
![]()
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|